COVID-19 in Immunocompromised Patients: A Systematic Review.
Semin Respir Crit Care Med
; 42(6): 839-858, 2021 12.
Article
in English
| MEDLINE | ID: covidwho-1768958
ABSTRACT
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first identified as a novel coronavirus in Wuhan, Hubei province, central China, in December 2019, and is responsible for the 2019-to-present pandemic. According to the most recent data released by the World Health Organization, more than 200 million people have been infected by SARS-CoV-2 so far, and more than 4 million people died worldwide. Although our knowledge on SARS-CoV-2 and COVID-19 is constantly growing, data on COVID-19 in immunocompromised patients are still limited. The aim of the present systematic review is to describe clinical picture, disease severity, proposed treatment regimen, and response to vaccination in patients with different types and severity of immunosuppression.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Immunocompromised Host
/
SARS-CoV-2
/
COVID-19
Type of study:
Prognostic study
/
Reviews
/
Systematic review/Meta Analysis
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Semin Respir Crit Care Med
Journal subject:
Critical Care
Year:
2021
Document Type:
Article
Affiliation country:
S-0041-1740110
Similar
MEDLINE
...
LILACS
LIS